Volume 6 Issue 2 - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Editorial Archive

Aseptic Pharmaceutical Processing: It All Begins in The Lab

The drive towards novel drug presentation and injectable-grade products is generating increased demand for aseptic pharmaceutical processing, including aseptic spray...

1 July 2014 Editorial Archive | Labs & Logistics V6I2 | Volume 6 Issue 2

Continue Reading →

Clinical Research V6I2

Label-free Cell-based Assay for Peptide-receptor Interaction Characterisation

Both the drug development process and fundamental studies of mechanisms underlying biological interactions require analytical methods that mimic the in vivo situatio...

1 July 2014 Clinical Research V6I2 | Editorial Archive | Volume 6 Issue 2

Continue Reading →

Clinical Research V6I2

Current Perspective on TBI

Dr Adrian Harel of Medicortex conveys the urgency of developing mitigating therapeutics for the secondary and long-term damaging effects of TBI. His article makes cl...

1 July 2014 Clinical Research V6I2 | Editorial Archive | Volume 6 Issue 2

Continue Reading →

Clinical Research V6I2

Ready for Battle: How Preclinical Development Brings New Vaccines to the War on Disease

Few medical advances have made as large an impact on world health as vaccines. Yet the battle isn’t over. As new infectious diseases emerge, as old ones grow resista...

1 July 2014 Clinical Research V6I2 | Editorial Archive | Volume 6 Issue 2

Continue Reading →

Drug Discovery, development & Delivery V6I2

Regulatory Focus on Nanomedicines in US and Europe

Vidhya Sabbella, Valluru Ravi, T. M. Pramod Kumar and K. Sreekanth Reddy, of JSS College of Pharmacy, JSS University, Mysore, give an overview of nanotechnology and ...

1 July 2014 Drug Discovery, development & Delivery V6I2 | Editorial Archive | Volume 6 Issue 2

Continue Reading →

Drug Discovery, development & Delivery V6I2

Outsourcing Computational Chemistry for Drug Discovery

Computational chemistry is a highly-skilled scientific field that has delivered proven results for drug discovery, particularly in the areas of lead identification a...

1 July 2014 Drug Discovery, development & Delivery V6I2 | Editorial Archive | Volume 6 Issue 2

Continue Reading →

Editorial Archive

Keeping Data Secure and Validated in the Cloud – Addressing the Misconceptions Surrounding Cloud Computing in Pharma

The requirement to demonstrate compliance, while still maintaining process efficiency and ease of use for marketing teams and time-to-market for life science compani...

1 July 2014 Editorial Archive | Regulatory & Marketplace V6I2 | Volume 6 Issue 2

Continue Reading →

Editorial Archive

Achieving Operational Excellence in Drug Safety with an Effective Quality Management System

The International Conference on Harmonisation (ICH), European Medicines Agency (EMA) and US Food and Drug Administration (US FDA) have laid out their expectations wi...

1 July 2014 Editorial Archive | Regulatory & Marketplace V6I2 | Volume 6 Issue 2

Continue Reading →

Editorial Archive

Merging and Acquisition Perspective in Pharmaceutical Industry

It is very difficult to estimate how many mergers and acquisitions in the pharmaceutical industry have succeeded. It is even more difficult to define what success me...

1 July 2014 Editorial Archive | Regulatory & Marketplace V6I2 | Volume 6 Issue 2

Continue Reading →

Editorial Archive

FDA Issues Guidance on Reporting Requirements for Web-Based Promotion of Drugs and Biologics

The FDA has finally given some guidance on what drug companies must do to comply with federal reporting requirements when marketing their products through social med...

1 July 2014 Editorial Archive | Regulatory & Marketplace V6I2 | Volume 6 Issue 2

Continue Reading →

Future-ready ADCs – advanced vial solutions for superior stability and performance

Alternative Drug Delivery Routes: Opportunities, Challenges, and How to Overcome Them

Bridging the gap between R&D and GMP

Current Edition

Current Edition

Subsection - CDMO

Subsection - Injectables

Subsection - Neurodegenerative Diseases

Subsection - Nasal & Pulmonary

Aseptic Pharmaceutical Processing: It All Begins in The Lab

Label-free Cell-based Assay for Peptide-receptor Interaction Characterisation

Current Perspective on TBI

Ready for Battle: How Preclinical Development Brings New Vaccines to the War on Disease

Regulatory Focus on Nanomedicines in US and Europe

Outsourcing Computational Chemistry for Drug Discovery

Keeping Data Secure and Validated in the Cloud – Addressing the Misconceptions Surrounding Cloud Computing in Pharma

Achieving Operational Excellence in Drug Safety with an Effective Quality Management System

Merging and Acquisition Perspective in Pharmaceutical Industry

FDA Issues Guidance on Reporting Requirements for Web-Based Promotion of Drugs and Biologics

International Pharmaceutical Industry